scholarly journals Anxiety and depression in end-stage COPD

2008 ◽  
Vol 31 (3) ◽  
pp. 667-677 ◽  
Author(s):  
K. Hill ◽  
R. Geist ◽  
R. S. Goldstein ◽  
Y. Lacasse
Keyword(s):  
Anxiety And Depression ◽  
End Stage

scholarly journals Family caregiver emotional distress in advanced cancer: the DME-C scale psychometric properties

2020 ◽  
pp. bmjspcare-2020-002608
Author(s):  
Joaquín T Limonero ◽  
Jorge Maté-Méndez ◽  
María José Gómez-Romero ◽  
Dolors Mateo-Ortega ◽  
Jesús González-Barboteo ◽  
...  
Keyword(s):  
Psychometric Properties ◽  
End Of Life ◽  
Family Caregivers ◽  
Advanced Cancer ◽  
Emotional Distress ◽  
Family Caregiver ◽  
Screening Tools ◽  
Anxiety And Depression ◽  
The Family ◽  
End Stage

BackgroundFamily caregivers of patients with advanced illness at end of life often report high levels of emotional distress. To address this emotional distress is necessary to have adequate and reliable screening tools.AimThis study analyses the psychometric properties and clinical utility of the Family Caregiver Emotional Detection Scale for caregivers of patients with end-stage cancer (DME-C, Spanish acronym) who are receiving palliative care (PC).DesignMulticentre, cross-sectional study.Settings/participantsFamily caregivers of patients with advanced cancer at end of life receiving palliative treatment were interviewed to explore their emotional distress through the DME-C scale and other instruments measuring anxiety and depression (Hospital Anxiety and Depression Scale (HADS)), distress thermometer (DT) and overload (B), as well as a clinical psychological assessment (CPA).Results138 family caregivers, 85 (61.6%) female and 53 (38.4%) male, with an average age of 59.69±13.3 participated in the study. The reliability of the scale, as measured by Cronbach’s alpha, was 0.76, and its stability over time was 0.734. Positive, significant correlations were found between the DME-C and the scores for anxiety and depression registered on the HADS scale, as well as with the total result of this latter scale and the results for B, the DT and the CPA. A statistical analysis of the receiver-operating characteristic curves showed that the scale has a sensitivity and specificity of 75%, and that the cut-off point for the detection of emotional distress was a score ≥11. Fifty-four per cent of the caregivers displayed emotional distress according to this scale.ConclusionsThe DME-C displays good psychometric properties. It is simple, short, reliable and easy to administer. We believe that the instrument is useful for the detection of emotional distress in the family caregivers of hospitalised patients suffering from end-stage illnesses and receiving PC.

A novel multidisciplinary approach to the management of end-stage macular disease

2021 ◽  
pp. 026461962110326
Author(s):  
Su Ling Young ◽  
Nathan Ng ◽  
Ngee Jin Yap ◽  
Zain Hussain ◽  
Peter D Cackett
Keyword(s):  
Low Vision ◽  
Holistic Approach ◽  
Depression Score ◽  
Anxiety And Depression ◽  
Macular Disease ◽  
Global Pandemic ◽  
Patient Reported ◽  
One Stop ◽  
End Stage ◽  
Endothelial Growth Factor

Introduction: In 2017, the Royal College of Ophthalmologists UK published ‘The Way Forward’ describing the effects of the ageing UK population on clinical demand for macular conditions. Although one-stop clinics have become accepted standard practice for combined assessment and injections, there is little guidance regarding eventual discharge of patients, and practice varies between clinicians. In 2018, NHS Lothian started a multidisciplinary one-stop clinic involving an Ophthalmologist, a Medical Photographer, a specialist Low Vision Optometrist, and a Low Vision Counsellor. We aimed to detail our experiences of this novel multidisciplinary discharge clinic for advanced macular disease patients. We also aimed to assess patient-reported anxiety and depression outcomes following this clinic. Retrospective data on 60 patients who attended the clinic from August 2018 to January 2019 were collected and included in analysis. Average age at presentation to the clinic was 85.76 ± 8.18 years old and patients had been followed up in the macula clinic for a mean of 4.80 ± 2.43 years prior to attending the clinic. In all, 31 patients responded to a survey on anxiety and depression using the Hospital Anxiety and Depression score (HADS). Three (10%) of the patients reported scores abnormal for anxiety, and there were no abnormal scores for depression. The clinic provides a holistic approach for end-stage macular disease patients and reduces unnecessary macular anti–vascular endothelial growth factor treatments and clinic review appointments. This is especially important now during the coronavirus SARS-CoV-2 global pandemic. This provides significant benefits to capacity for delivery of clinical services and facilitates a safe and supported discharge for patients.

To kill two birds with a stone

2021 ◽  
pp. 1-3
Author(s):  
Saara Ahmad ◽  
Asra Khan ◽  
Prashant Tikmani ◽  
Hamna Rafiq
Keyword(s):  
Viral Infections ◽  
Anxiety And Depression ◽  
Vicious Cycle ◽  
Herbal Tea ◽  
Neuroprotective Effects ◽  
Traditional Remedies ◽  
Pleasant Surprise ◽  
Cytokine Cascade ◽  
The Uk ◽  
End Stage

Novel Corona virus 2019, its infectivity and pandemic around the world has earnestly garnered much panic, especially, with its new strain spreading across the UK and possibly its spread across borders. This has increased anxiety and stress levels to many folds mainly due to its robustness and resistance to treatment (1). The panic and paranoia of testing COVID-19 positive, restraining into isolation and being shunned by the society often lead to a vicious cycle of heightened stress, anxiety and depression levels in individuals that at times lead to the ugly consequences of COVID-19 rendering end stage in affected with admissions in the intensive care or even death upon arriving hospitals. China, the first ever country in world to announce COVID-19 infection, has successfully controlled and contained the infection (2). There the new cases are negligible and has shown its capacity of treatment of COVID-19 through utility of medicinal herbs and old traditional remedies that are long ago forgotten by the other nations. The commonest treatment modality against COVID-19 in China, Thailand and other Buddhist countries are through mere inhaling of steam and intake of herbal teas (3). Many studies have shown that any form of tea especially chamomile tea is beneficial in the treatment of COVID 19. We have also currently run a clinical trial at the Aga Khan University where chamomile and saffron tea was given in twice a day dose for a month to the depressed patients to treat their depression. To our pleasant surprise many participants of the trial knew that chamomile is also effective against viral infections. Our research has shown that saffron and chamomile in combination at reduced doses has synergistic antioxidant and anti-inflammatory and neuroprotective effects through modulation of neurotransmitters in brain (4,5). It is suggested that this synergism may benefit individuals against cytokine cascade, oxidant activity and inflammatory effects of the COVID 19 as well as alleviate neuropsychological deficits like anxiety, stress and depression that are associated with the fear of catching this communicable infection. This herbal tea may indeed help to kill two birds COVID-19 and neuropsychological illness with a stone. Continuous...

Perceived Mental Health and Disablement of Primary Care and End-Stage Renal Disease Patients

1997 ◽  
Vol 27 (1) ◽  
pp. 33-45 ◽  
Author(s):  
George R. Parkerson ◽  
Robert A. Gutman
Keyword(s):  
Mental Health ◽  
Social Support ◽  
Primary Care ◽  
End Stage Renal Disease ◽  
Severity Of Illness ◽  
Anxiety And Depression ◽  
Depression Symptoms ◽  
Stage Renal Disease ◽  
End Stage ◽  
Esrd Patients

Objective: To compare perceived current mental health and disablement between primary care and end-stage renal disease (ESRD) patients, and to study social support and stress and severity of illness as possible determinants of mental health and disablement. Method: Observational cross-sectional analysis of 414 primary care patients in a rural community health center and 125 ESRD patients requiring hemodialysis in two community dialysis units. The Duke Health Profile (DUKE) anxiety-depression scale was used to assess mental health; the DUKE disability scale, to indicate disablement; the Duke Social Support and Stress Scale, to measure support and stress; and the Duke Severity of Illness Scale, to rate severity of illness. Results: Perceived current mental health in terms of anxiety and depression symptoms was worse for primary care than for ESRD patients, and perceived current disablement was no different for the two groups. Patients' perception of their health status and of stress from family members were more closely associated with their level of anxiety and depression symptoms than were their diagnostic profiles or overall severity of illness. In turn, their level of anxiety and depression symptoms was the principal correlate of their disablement. Conclusions: The demonstration of strong relationships among anxiety and depression symptoms, disablement, and family stress in these two very different patient populations should stimulate further research and motivate clinicians to evaluate all three parameters as part of routine patient care.

scholarly journals ASSOCIATION BETWEEN FATIGUE AND EXERCISE CAPACITY IN PATIENTS WITH CHRONIC LIVER DISEASE AWAITING LIVER TRANSPLANTATION

2019 ◽  
Vol 56 (3) ◽  
pp. 252-255
Author(s):  
Yolanda de B LIMA ◽  
Clarissa B A MAGALHÃES ◽  
José Huygens P GARCIA ◽  
Cyntia F G VIANA ◽  
Geisyani Francisca G PRUDENTE ◽  
...  
Keyword(s):  
Liver Disease ◽  
Chronic Liver Disease ◽  
Exercise Capacity ◽  
Fatigue Severity Scale ◽  
Step Test ◽  
Anxiety And Depression ◽  
Severity Scale ◽  
End Stage Liver Disease ◽  
Fatigue Severity ◽  
End Stage

ABSTRACT BACKGROUND: Fatigue is highly prevalent in end stage liver disease, the studies about its association with exercise capacity in cirrhotic patients before liver are scarse. OBJECTIVE: In this study, we evaluated fatigue in 95 in end stage liver disease patients awaiting transplantation, compared to healthy volunteers, and tested the association between exercise capacity and fatigue. METHODS: Cross-sectional study of patients with chronic liver disease treated at a referral center in Fortaleza, Brazil. Fatigue was quantified with the Fatigue Severity Scale. The patients were submitted to the 6-min walk test, the 6-min step test, the Hospital Anxiety and Depression Scale, C-reative protein measurement and hematocrit count, measurement of dyspnea among other tests. Fatigue data were obtained from healthy individuals for comparison with patients. RESULTS: The mean age of patients was 45.9±12.3 years, and 53.7% were male. Fatigue, anxiety and depression levels were higher among end stage liver disease patients than among controls. A negative correlation was observed between 6 min step test and Fatigue Severity Scale score (r= -0.2; P=0.02) and between hematocrit count and Fatigue Severity Scale score (r= -0.24; P=0.002). Dyspnea on the Borg scale and fatigue were positively correlated (r=31; P=0.002). In the multivariate analysis, low 6-min step test values and high levels of dyspnea were associated with fatigue. CONCLUSION: Fatigue was more prevalent and severe in end stage liver disease patients than in healthy controls. Low 6MST values and high levels of dyspnea were associated with fatigue in this scenario.

The positive influence of psychological intervention on the level of anxiety and depression in dialysis patients: A pilot study

2019 ◽  
Vol 42 (4) ◽  
pp. 167-174 ◽  
Author(s):  
Kamilla Bargiel-Matusiewicz ◽  
Agnieszka Łyś ◽  
Paulina Stelmachowska
Keyword(s):  
End Stage Renal Disease ◽  
Narrative Therapy ◽  
Cognitive Intervention ◽  
Anxiety And Depression ◽  
Control Group ◽  
Dialysis Patients ◽  
Dialysis Therapy ◽  
Narrative Intervention ◽  
Stage Renal Disease ◽  
End Stage

Medical progress in dialysis therapy made it possible to treat patients with the end-stage renal disease for many years. But at the other side it may lead to profound changes in everyday life and may induce depression and anxiety. The research presented in this article explores the influence of psychological interventions on anxiety and depression levels in patients undergoing dialysis therapy. The experimental design included two experimental groups: cognitive intervention and cognitive/narrative intervention and one control group (standard treatment). In total, 139 participants aged 22–75, including 67 women and 72 men diagnosed with end-stage renal disease and treated with dialysis, were divided into a control group and two experimental groups. Two well-known tools were used in the study: Beck Depression Inventory and State-Trait Anxiety Inventory. It was indicated that cognitive intervention may decrease the level of anxiety as a state, whereas cognitive/narrative intervention may decrease the level of anxiety as a state and the level of depression in dialysis patients. The stronger effect in the case of using narrative therapy may be the consequence of the fact that narrative therapy stimulates deeper analysis of the discussed issues (involving emotional level).

scholarly journals The prevalence of anxiety and depression among end-stage renal disease patients on hemodialysis in Saudi Arabia

Renal Failure ◽  
2014 ◽  
Vol 36 (10) ◽  
pp. 1510-1515 ◽  
Author(s):  
Ibrahim Turkistani ◽  
Abdulelah Nuqali ◽  
Mohammed Badawi ◽  
Omar Taibah ◽  
Omar Alserihy ◽  
...  
Keyword(s):  
Saudi Arabia ◽  
Renal Disease ◽  
End Stage Renal Disease ◽  
Anxiety And Depression ◽  
Stage Renal Disease ◽  
End Stage
Sign in / Sign up

Export Citation Format

Share Document